NCT01489891View on ClinicalTrials.gov

Usefulness of Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopy Under Sedation With Propofol

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions
Esophagogastroduodenoscopy
Interventions
DRUG

Lidocaine

Applying of 5 puff controlled released (50 mg) transoral spray of lidocaine (10 mg=1 puff).

DRUG

Placebo

Applying of 5 puff controlled released (50 mg) transoral spray of placebo (excipients of trade mark of lidocaine ensuring the patient masking).

Trial Locations (1)

28980

Hospital Universitario Infanta Cristina, Parla

All Listed Sponsors
lead

Hospital Universitario Infanta Cristina

OTHER

NCT01489891 - Usefulness of Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopy Under Sedation With Propofol | Biotech Hunter | Biotech Hunter